From Technology
to Treatment

Advancing Precision Medicine

28 & 29 August 2025

ETH Zurich, Main Building

About the Event

This two-day event will explore the latest breakthroughs in personalized medicine, with a particular focus on how cutting-edge technologies transform clinical practice and patient care. Leading experts from academia, medicine, and industry will come together to share insights, discuss challenges, and shape the future of precision medicine.

Key Highlights:

  • Keynote lectures on the latest advances in personalized medicine in Switzerland and abroad.
  • panel discussion with renowned leaders from academia, healthcare, patients and industry, addressing the current state and future opportunities of personalized medicine.
  • Presentations of groundbreaking projects that are translating research into real-world clinical applications.
  • Opportunities to explore national and international collaborations and synergies that will advance the field.

PHRT & SPHN

The PHRT – SPHN Event 2025 brings together leading researchers, clinicians, policymakers, and industry experts to showcase the advancements in Personalized Medicine and Health in Switzerland. This event serves as a platform to highlight the impact of PHRT – Personalized Health & Related Technologies and Swiss Personalized Health Network (SPHN), fostering collaboration and innovation in the field.

Our Speakers

Prof. Sir Mark Caulfield

Vice Principal for Health, Director of the NIHR Barts Biomedical Research Centre, Former Chief Scientist at Genomics England

Queen Mary University of London

Dr. Dean Ho

Provost’s Chair Professor, Director of the N.1 Institute for Health (N.1). Director of the Institute for Digital Medicine (WisDM), Head of the Department of Biomedical Engineering

National University of Singapore

Prof. Dr. Adam Lewandowski

Deputy Chief Scientist for UK Biobank and Associate Professor at University of Oxford

UK Biobank

Prof. Dr. Sebastian Kozerke

Full Professor at the Department of Information Technology and Electrical Engineering

ETHZ

Prof. Dr. Barend Mons

Founding director of the Leiden Institute for FAIR and Equitable Science (LIFES)

Leiden University, the Netherlands

Prof. Dr. Annette Oxenius

Full Professor at the Department of Biology & Vice-President for Research (as of August 2025)

ETH Zurich

Dr. Michael Rebhan

Scientist at NIBR Basel

Novartis

Prof. Dr. Christian Rüegg

Director of PSI, Member of the ETH Board

PSI, ETH Board

Dr. Monika Jänicke

CEO & Chairwoman of the Hospital Management Board

University Hospital Zurich

Prof. Dr. Antoine Geissbühler

Dean of the faculty of medicine, University of Geneva; Director, teaching and research.

Geneva University Hospitals

Dr. Jasmim Barman-Aksözen

Scientist and patient advocate for rare diseases

University of Zurich

Dr. Davide Chiarugi

Technical Director SPHN

SPHN

Prof. Dr. Andre Dekker

Professor of Clinical Data Science and board certified Medical Physicist

Maastricht University, the Netherlands

Dr. Marija Buljan

Research Group Lead

Empa, Group Multi-omics for healthcare materials

Prof. Dr. Charlotte Bunne

Tenure Track Assistant Professor

EPFL, Artificial Intelligence in Molecular Medicine Laboratory (AIMM)

Dr. Adrien Coulet

Researcher and co-leader of the HeKA team

L’institut national de recherche en sciences et technologies du numérique (Inria), France

Prof. Dr. Catherine Jutzeler

Assistant Professor at the Department of Health Sciences and Technology

ETHZ

Dr. Katrin Crameri, MPH

Co-Lead DigiSanté, Federal Department of Home Affairs

Digital Transformation Division, Swiss Federal Office of Public Health (FOPH)

Prof. Dr. Dr. Damian Wild

Head of Nuclear Medicine at University Hospital Basel

University Hospital Basel

Prof. Dr. Arnaud Perrier

President SAMS

Swiss Academy of Medical Sciences (SAMS)

Prof. Dr. Roger Schibli

Head of Center for Radiopharmaceutical Sciences

PSI, Center for Radiopharmaceutical Sciences

Prof. Dr. Olivier Michielin

Head of Oncology Department

Geneva University Hospital

PD Dr. Sean Froese

Head of Research Metabolic diseases

University Children's Hospital Zurich

Prof. Dr. Alexandre Theocharides

Head of Clinical Studies CCCZ, Clinic for Medical Oncology and Haematology

University Hospital Zurich

Prof. Dr. Berend Snijder

Institute of Molecular Systems Biology, ETH Zurich

ETHZ

Dr. Thomas Geiger

SPHN Managing Director

SPHN

Dr. Sandra Goetze

SMOC Coordinator

ETH PHRT Swiss Multi-Omics Center

Prof. Dr. Matthias Baumgartner

Chair of the SPHN National Steering Board

SPHN

Prof. Dr. Bernd Wollscheid

Chair of the PHRT Executive Committee

PHRT

Dr. Daniel Vonder Mühl

Executive Director PHRT

PHRT

Event Agenda

August 28, 2025

07:30 – 08:30Arrival, Coffee, Registration
08:30 – 08:45Welcome Address, Prof. Dr. Arnaud Perrier (President SAMS) & Bernd Wollscheid (PHRT EC Chair)
08:45 – 09:30Precision Medicine – Transforming Healthcare, Prof. Sir Mark Caulfield (Vice Principal for Health, Director of the NIHR Barts Biomedical Research Centre at Queen Mary University of London & Former Chief Scientist at Genomics England) Link to Abstract
09:30 – 10:00Reflecting on 8 Years of Progress: An Overview of the PHRT and SPHN Initiatives, Prof. Dr. Bernd Wollscheid & Prof. Dr. Matthias Baumgartner (SPHN National Steering Board Chair) & Prof. Dr. Bernd Wollscheid (PHRT EC Chair)
10:00 – 10:30Coffee Break / Poster Exhibition & Booths

Multi-Omics: Mapping the Complexities of Life

10:30 – 11:00
Enhancing rare disease diagnosis through multi-omics, PD Dr. Sean Froese (Head of Research Metabolic diseases at University Children’s Hospital Zurich)
11:00 – 11:15Advancing Precision Medicine with Integrated Multi-Omics Approaches, Dr. Sandra Goetze (SMOC Coordinator)
11:15 – 11:30Charting cellular plasticity through multi-omics profiling and data integration, Dr. Marija Buljan (Research Group Lead, Group Multi-omics for healthcare materials at Empa)
11:30 – 12:00Poster Pitches
12:00 – 13:00Lunch / Poster Exhibition & Booths

Innovating PM: Systematic Data Generation for Impact

13:00 – 13:20SPO-NDS: Fueling Precision Oncology in Switzerland, Prof. Dr. Olivier Michielin (Head of Oncology Department at Geneva University Hospital)
13:20 – 13:40From Data to Decisions: Leveraging the National IICU Data Stream, Prof. Dr. Catherine Jutzeler (Assistant Professor at the Department of Health Sciences and Technology at ETH Zurich)
13:40 – 14:00DigiSanté – Transforming Swiss Healthcare Through Digitalization, Dr. Katrin Crameri (Co-Lead DigiSanté at the Federal Department of Home Affairs)
14:00 – 14:30Coffee Break / Poster Exhibition & Booths

Next Generation Technology: Redefining Possibilities

14:30 – 15:30The RAPID-01 Trial: Personalized therapy for acute myeloid leukemia patients, Prof. Dr. Berend Snijder, (Institute of Molecular Systems Biology at ETH Zurich), Prof. Dr. Alexandre Theocharides (Head of Clinical Studies CCCZ at the Clinic for Medical Oncology and Haematology, University Hospital Zurich)
15:30 – 16:15Imaging in population science and digital twinning for precision cardiology, Prof. Dr. Adam Lewandoswki (Deputy Chief Scientist for the UK Biobank and Associate Professor at University of Oxford), Prof. Dr. Sebastian Kozerke (Full Professor at the Department of Information Technology and Electrical Engineering at ETH Zurich)
16:15 – 18:00Apéro, Exhibition & Networking

August 29, 2025

08:00 – 08:45Arrival, Coffee
08:45 – 09:00Welcome Address, Dr. Davide Chiarugi (Technical Director SPHN) & Dr. Daniel Vonder Mühll (Executive Director PHRT)
09:00 – 10:00Panel: From Discovery to Application: Navigating the Future of Personalized Medicine with 

Jasmin Barman-Aksözen (Scientist and patient advocate for rare diseases)

Dr. Katrin Crameri (Co-Lead DigiSanté at the Federal Department of Home Affairs)

Prof. Dr. Antoine Geissbühler (Dean of the faculty of medicine, University of Geneva; Director, teaching and research at Geneva University Hospitals)

Dr. Monika Jänicke (CEO & Chairwoman of the Hospital Management Board at University Hospital Zurich)

Prof. Dr. Anette Oxenius (Full Professor at the Department of Biology & Vice-President for Research (as of August 2025) at ETH Zurich)

Dr. Michael Rebhan (Scientist at NIBR Basel, Novartis)

Prof. Dr. Christian Rüegg (Director of PSI, Member of the ETH Board)
10:00 – 10:30Coffee Break / Poster Exhibition & Booths

FAIR Principles: Overcoming Challenges in Data Accessibility and Integration

10:30 – 11:00Stop data sharing, Prof. Dr. Barend Mons (Founding director of the Leiden Institute for FAIR and Equitable Science (LIFES), Leiden University, the Netherlands)
11:00 – 11:30Predicting clinical outcomes from patient care pathways represented with temporal knowledge graphs, Dr. Adrian Coulet (Researcher and co-leader of the HeKA team at  L’institut national de recherche en sciences et technologies du numérique (Inria), France)
11:30 – 12:00Poster Pitches
12:00 – 13:00Lunch / Poster Exhibition & Booths

Radiotheragnostics: Transforming Precision Medicine with Targeted Therapies

13:00 – 14:00Exploring the next Generation of Radiotheragnostics formetastaticProstate Cancer, Prof. Dr. Roger Schibli (Head of Center for Radiopharmaceutical Sciences at PSI) & Prof. Dr. Dr. Damian Wild (Head of Nuclear Medicine at University Hospital Basel)
14:00 – 14:20Coffee Break / Poster Exhibition & Booths

Shaping Tomorrow: The Power of AI and Federated Computing

14:20 – 14:30Appreciation
14:30 – 15:15Precision Begins With One, Dr. Dean Ho (Head of the Department of Biomedical Engineering at the National University of Singapore)
15:15 – 16:00Federated Learning from FAIR data, Prof. Dr. Andre Dekker (Professor of Clinical Data Science at Maastricht University, the Netherlands)
16:00 – 16:30Virtual Cells and Digital Twins: AI in Personalized Oncology, Dr. Charlotte Bunne (Tenure Track Assistant Professor at the Artificial Intelligence in Molecular Medicine Laboratory, EPFL)
16:30 – 17:00Closing Remarks / Acknowledgements / Poster Award Prof. Dr. Bernd Wollscheid (EC Chair PHRT), Dr. Thomas Geiger (Managing Director SPHN)

Achievements of PHRT & SPHN

500+ Researchers

A growing community

700,000+ Patients

Gave general consent

250+ Projects

Funded to advance precision medicine.

40+ Hospitals

Collaborating on research

Ethical & Legal Support

For multicenter studies

BioMedIT Platform

Trusted research environment

Location

ETH Zürich, Main Building, Switzerland